Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS20070142696 A1
Type de publicationDemande
Numéro de demandeUS 11/635,283
Date de publication21 juin 2007
Date de dépôt7 déc. 2006
Date de priorité8 déc. 2005
Autre référence de publicationUS8858416, US20140005466, US20150031938
Numéro de publication11635283, 635283, US 2007/0142696 A1, US 2007/142696 A1, US 20070142696 A1, US 20070142696A1, US 2007142696 A1, US 2007142696A1, US-A1-20070142696, US-A1-2007142696, US2007/0142696A1, US2007/142696A1, US20070142696 A1, US20070142696A1, US2007142696 A1, US2007142696A1
InventeursPeter Crosby, John Woodard
Cessionnaire d'origineVentrassist Pty Ltd
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet
Implantable medical devices
US 20070142696 A1
Résumé
An active implantable medical device comprising a therapeutic device, a controller and at least one rechargeable battery, wherein a single hermetically sealed housing encapsulates a therapeutic device, controller and rechargeable battery. A hermetically sealed housing additionally encapsulates a wireless interface and a commutator.
Images(5)
Previous page
Next page
Revendications(10)
1. An active implantable medical device comprising a therapeutic device, a controller and at least one rechargeable battery, wherein a single hermetically sealed housing encapsulates said therapeutic device, said controller and said rechargeable battery.
2. The active implantable medical device as claimed in claim 1, wherein said hermetically sealed housing additionally encapsulates a wireless interface.
3. The active implantable medical device as claimed in claim 1, wherein said hermetically sealed housing additionally encapsulates a commutator.
4. The active implantable medical device as claimed in claim 1, wherein said therapeutic device is a rotary blood pump.
5. The active implantable medical device as claimed in claim 1, wherein a percutaneous lead is connected thereto.
6. The active implantable medical device as claimed in claim 1, wherein a TETS is connected thereto.
7. An active implantable medical device comprising a therapeutic device, a controller, an electrically conductive coil and at least one rechargeable battery, wherein a first hermetically sealed housing encapsulates said controller, said electrically conductive coil and said rechargeable battery.
8. An active implantable medical device as claimed in claim 7, wherein a second hermetically sealed housing encapsulates said therapeutic device.
9. An active implantable medical device comprising a therapeutic device, a controller, an electrically conductive coil and at least one rechargeable battery, wherein a first hermetically sealed housing encapsulates said electrically conductive coil and said rechargeable battery.
10. A controller for a therapeutic device disposed within an active implantable medical device, said controller and said therapeutic device adapted to be powered by at least one rechargeable battery, wherein said controller and said therapeutic device and said rechargeable battery are all housed within a single hermetically sealed housing.
Description
    FIELD OF THE INVENTION
  • [0001]
    The present invention relates to improvements to active implantable medical devices. An active implantable medical device may generally include a power source (e.g. a battery), control means (e.g. an electronic circuit) and a means providing the therapeutic action (e.g. an electrode or mechanical pump).
  • BACKGROUND OF THE INVENTION
  • [0002]
    An active implantable medical device in which the means providing the therapeutic action is an electrode system (e.g.: a pacemaker or implantable defibrillator) can often be constructed in such a way that all the components with the exception of the means providing the therapeutic action are enclosed inside a single package, which is usually hermetically sealed. However, more complicated active implantable medical devices, or those in which the therapeutic action is mechanical in nature (such as the AbioCor™ fully implantable artificial heart by Abiomed, Danvers, Mass., USA), have in the past, been implanted in multiple components having separate hermetically sealed housings for each implanted component. Typically, the implanted components included a controller, at least one battery, and a therapeutic device. For purposes of this specification, a therapeutic device means a medical device that: actively treats a medical condition of a patient, and requires a power source to operate. Examples of therapeutic devices include, but are not limited to: pacemakers, left ventricle assist devices, cochlear implants, implanted hearing aids, and neural simulators.
  • [0003]
    As each implanted component generally includes a separate hermetic sealed housing, the implanted medical devices are often bulky and cumbersome. The increased surface area of multiple hermetical sealed housings may lead to increased risk of infection for patients implanted with such a device. Additionally, multiple implanted components add to the manufacturing cost, and may compromise the system reliability.
  • [0004]
    U.S. Pat. No. 6,269,266—Leysieffer and U.S. Pat. No. 6,736,770—Leysieffer et al describe similar implantable medical devices wherein a therapeutic device and at least one battery are packaged together in hermetically sealed housing and implanted within the body of a patient. However, the devices described within these disclosures are limited to including a therapeutic device with a battery and do not include a controller or device controller within the said hermetically sealed housing. Thereby the devices may require a separate implanted controller with additional housing or the controller may be required to be carried externally relative to the patient.
  • [0005]
    The present invention aims to or at least address or ameliorate one or more of the disadvantages associated with the above mentioned prior art.
  • BRIEF DESCRIPTION OF THE INVENTION
  • [0006]
    In accordance with a first aspect the present invention consists of an active implantable medical device comprising a therapeutic device, a controller and at least one rechargeable battery, wherein a single hermetically sealed housing encapsulates said therapeutic device, said controller and said rechargeable battery.
  • [0007]
    Preferably, said hermetically sealed housing additionally encapsulates a wireless interface.
  • [0008]
    Preferably, said hermetically sealed housing additionally encapsulates a commutator.
  • [0009]
    Preferably, said therapeutic device is a rotary blood pump.
  • [0010]
    Preferably, a percutaneous lead is connected thereto.
  • [0011]
    Preferably, a TETS is connected thereto.
  • [0012]
    In accordance with a second aspect the present invention consists of an active implantable medical device comprising a therapeutic device, a controller, an electrically conductive coil and at least one rechargeable battery, wherein a first hermetically sealed housing encapsulates said controller, said electrically conductive coil and said rechargeable battery.
  • [0013]
    Preferably, a second hermetically sealed housing encapsulates said therapeutic device.
  • [0014]
    In accordance with a third aspect the present invention consists of an active implantable medical device comprising a therapeutic device, a controller, an electrically conductive coil and at least one rechargeable battery, wherein a first hermetically sealed housing encapsulates said electrically conductive coil and said rechargeable battery.
  • [0015]
    In accordance with a fourth aspect the present inventions consists of a controller for a therapeutic device disposed within an active implantable medical device, said controller and said therapeutic device adapted to be powered by at least one rechargeable battery, wherein said controller and said therapeutic device and said rechargeable battery are all housed within a single hermetically sealed housing.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0016]
    Embodiments of the present invention will now be described with reference to the accompanying drawings wherein:
  • [0017]
    FIG. 1 depicts a front cross-sectional view of a first embodiment of the preferred invention;
  • [0018]
    FIG. 2 depicts a schematic view of a second embodiment of the preferred invention;
  • [0019]
    FIG. 3 depicts a schematic view of a third embodiment of the preferred invention; and
  • [0020]
    FIG. 4 depicts a schematic view of a fourth embodiment of the preferred invention.
  • BRIEF DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0021]
    In a first preferred embodiment of the present invention, as depicted in FIG. 1, an active implantable medical device 16 is shown. In this embodiment, the active implantable medical device 16 includes rotary blood pump 5 comprising: a DC brushless motor comprising stator coils 7 mounted on opposed sides of an impeller 11. The impeller 11 includes permanent encapsulated magnets (not shown) which interact and cooperate with the stator coils 7, when sequentially energised. Preferably, the stator coils are energised in a manner to facilitate the imparting of a magnetic torque force on the impeller 11 to encourage the impeller 11 to rotate within a cavity of a housing 1. The impeller 11 preferably includes four blades 9 connected by struts 10. The blades 9 preferably include a hydrodynamic bearing surface on the upper and lower surfaces of the blades 9, which provide a means for hydrodynamic suspension when the impeller 11 is rotating at a sufficient speed.
  • [0022]
    Preferably, blood is urged from an inlet 17 to an outlet 8 by the centrifugal motion imparted by the rotating motion of the impeller 11. The preferred blood path 6 through the blood pump 5 is shown diagrammatically in FIG. 1.
  • [0023]
    A similar blood pump to the blood pump 5 of the first preferred embodiment is described in U.S. Pat. No. 6,227,797—Watterson et al and the description of that disclosure is herein included within this current embodiment.
  • [0024]
    In this first preferred embodiment, the active implantable medical device 16 has a hermetically sealed housing 1 that encapsulates: a therapeutic device, namely the mechanical components of the blood pump 5 (i.e. the impeller 11, stators 7, inlet 17 and outlet 8); a rechargeable battery 3, and a controller 12 or pump controller. All of these implanted components are integrated and encapsulated into the one hermetically sealed housing 1.
  • [0025]
    Preferably, the therapeutic device portions are mechanically operable. An example of a mechanical operable therapeutic device is the pumping motion of the impeller within the rotary blood pump 5.
  • [0026]
    The hermetically sealed housing 1 preferably encapsulates the therapeutic device portions, the rechargeable battery 3, and the controller 12. This encapsulation allows all of the implanted components of the blood pump 5 to be positioned and mounted within the single housing 1. This significantly reduces the surface area required by the entire active implantable medical device 16 by concentrating the volume of the active implantable medical device 16 in one area. Additionally, the implantation of the active implantable medical device 16 with a patient may be significantly easier and quicker for the clinician as there are fewer objects being implanted. A further advantage may be that having only a single housing 1 reduces the risk of infection, as the risk of infection is generally proportional to the surface area of the active implantable medical device 16.
  • [0027]
    In the first preferred embodiment of the present invention, the hermetically sealed housing 1 is moulded around the internal components of the active implantable medical device 16. However, the housing 1 may alternatively encapsulate the implanted components by encasing the internal components in an alloy shroud, preferably titanium alloy, which is hermetically sealed by welding.
  • [0028]
    Preferably, the controller 12 receives instructions, data and power via a percutaneous lead 2 which exits the patient and electrically connects to an external power source (not shown in FIG. 1) or external controller (not shown in FIG. 1). The controller 12 also includes a commutator circuit and sequentially energises the stators 7 to produce the rotational torque drive force on the impeller 11 in accordance with a speed signal derived by the controller 12. The controller 12 also is electrically connected to the rechargeable battery 3. The controller 12 uses the rechargeable battery 3 as a means for storing an electrical charge so that if the percutaneous lead 2 is disconnected the pump may continue to operate. Preferably, the rechargeable battery 3 is charged when the percutaneous lead 2 is connected to an external power source.
  • [0029]
    Preferably, the controller 12 may operate in a manner similar to the control method described in U.S. Pat. No. 6,866,625—Ayre et al. and the description of this disclosure is herein included within the present specification.
  • [0030]
    Preferably, the rechargeable battery 3 may include at least one rechargeable battery and this rechargeable battery may be of any type. Preferably, the type of battery included within the active implantable medical device 16 is a Lithium Ion rechargeable battery supplying a 12V power supply.
  • [0031]
    A second preferred embodiment, similar to first preferred embodiment, is depicted in FIG. 2. In the second preferred embodiment, the rotary blood pump 5 is driven by a commutator 4 which receives a drive signal from the pump controller 12.
  • [0032]
    Preferably in the second embodiment, the pump controller 12 may be able to selectively switch between the two power sources depending on the circumstances and the power requirements of the active implantable medical device 16.
  • [0033]
    Additionally in the second preferred embodiment, the commutator circuit 4 is shown as a separate component within the hermetically sealed housing 1. The commutator circuit 4 in this embodiment is also maintained and controlled by the pump controller 12.
  • [0034]
    FIG. 2 also depicts diagrammatically the manner by which the percutaneous lead 2 exits the skin layer 17 of the patient and connects to an external power supply 13. Preferably, the active implantable medical device 16 is also electrically connected to the external controller and/or data manager 14 (herein referred to as ECDM 14). The ECDM 14 may serve as a backup controller in situations where the pump controller 12 fails. Additionally, the ECDM 14 may manage and store relevant patient or active implantable medical device 16 data. The data may be received from the pump controller 12 through the percutaneous lead 2. Preferably, the ECDM 14 maybe a personal computer or laptop computer running software designed specifically for the purpose of an active implantable medical device control and/or an active implantable medical device data management.
  • [0035]
    The pump controller 12 may also be electrically connected to a wireless interface 15 as depicted in FIG. 2. The wireless interface 15 is also preferably encapsulated within the hermetically sealed housing 1.
  • [0036]
    Preferably, the wireless interface 15 is able to transmit and receive data and instructions without the use of the percutaneous lead 2. Thereby the pump controller 12 may be able to wirelessly transmit and receive data and instructions to and from the ECDM 14. Preferably, any wireless interface protocol may be used including, but not limited to: Bluetooth™; Zigbee™; Wi-Fi™; 802.11a, b, & g.
  • [0037]
    The external power supply 13 maybe a mains power connection which is rectified to provide the required power for the active implantable medical device 16 and/or it may also be rechargeable or long life batteries.
  • [0038]
    Alternatively, the percutaneous lead 2 may be replaced with the transcutaneous energy transfer system (herein referred to as ‘TETS’). TETS generally comprises a two electrical conductive coils positioned either side of the skin layer 17 of a patient. When a first coil energises an electrical current is induced the second coil and whereby allowing the transmission of energy and data via the TETS. The main advantage of TETS is that the patient is not required to have a permanent exit wound from which the percutaneous lead 2 extends. Additionally, one of the said coils may be included within the housing 1 and would further minimise the amount of components to be implanted within a patient.
  • [0039]
    In a third embodiment of the present invention is depicted in FIG. 3, wherein a therapeutic device is hermetically sealed in a housing 1 with a controller 12, commutator 4 and wireless interface 15. The preferred therapeutic device for use with this second embodiment is a rotary blood pump 5. A battery is housed within a second hermetically sealed housing 20 along with a first electrical conductive coil 21 of a TETS. The first coil 21 implanted beneath the skin layer 17 interacts with a second electrically coil 23 above the skin layer 17. The first and second coils 21 & 23 interact by one coil inducing an electrical current in the opposed coil and thereby allowing the transmission and receipt of electrical energy and also coded data transmission across the transmission link 22 which formed between the first and second coils 21 and 23.
  • [0040]
    In a fourth embodiment of the present invention is depicted in FIG. 4, wherein a controller 12 and a battery 3 and a first coil 21 of the TETS are hermetically sealed within a second housing 20. A therapeutic device is hermetically sealed within a first housing 1.
  • [0041]
    The above descriptions detail only some of the embodiments of the present invention. Modifications may be obvious to those skilled in the art and may be made without departing from the scope and spirit of the present invention.
Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
US5211546 *11 mai 199218 mai 1993Nu-Tech Industries, Inc.Axial flow blood pump with hydrodynamically suspended rotor
US5279292 *13 févr. 199218 janv. 1994Implex GmbhCharging system for implantable hearing aids and tinnitus maskers
US5289821 *30 juin 19931 mars 1994Swartz William MMethod of ultrasonic Doppler monitoring of blood flow in a blood vessel
US5370509 *8 déc. 19936 déc. 1994The Cleveland Clinic FoundationSealless rotodynamic pump with fluid bearing
US5569156 *9 sept. 199429 oct. 1996Ottawa Heart Institute Research CorporationElectrohydraulic ventricular assist device
US5613935 *16 déc. 199425 mars 1997Jarvik; RobertHigh reliability cardiac assist system
US5695471 *20 févr. 19969 déc. 1997Kriton Medical, Inc.Sealless rotary blood pump with passive magnetic radial bearings and blood immersed axial bearings
US5713939 *16 sept. 19963 févr. 1998Sulzer Intermedics Inc.Data communication system for control of transcutaneous energy transmission to an implantable medical device
US5733313 *1 août 199631 mars 1998Exonix CorporationRF coupled, implantable medical device with rechargeable back-up power source
US5840070 *13 août 199724 nov. 1998Kriton Medical, Inc.Sealless rotary blood pump
US5947892 *13 déc. 19967 sept. 1999Micromed Technology, Inc.Rotary blood pump
US5980448 *28 janv. 19989 nov. 1999Vascor, Inc.Single chamber blood pump
US6053705 *26 sept. 199625 avr. 2000Sulzer Electronics AgRotary pump and process to operate it
US6066086 *4 mars 199823 mai 2000Nimbus, Inc.Speed control system for implanted blood pumps
US6067474 *31 juil. 199823 mai 2000Advanced Bionics CorporationImplantable device with improved battery recharging and powering configuration
US6071093 *18 oct. 19966 juin 2000Abiomed, Inc.Bearingless blood pump and electronic drive system
US6080133 *1 juil. 199827 juin 2000Kriton Medical, Inc.Sealless rotary blood pump
US6100618 *2 avr. 19968 août 2000Sulzer Electronics AgRotary machine with an electromagnetic rotary drive
US6120537 *23 déc. 199719 sept. 2000Kriton Medical, Inc.Sealless blood pump with means for avoiding thrombus formation
US6158984 *28 déc. 199812 déc. 2000Kriton Medical, Inc.Rotary blood pump with ceramic members
US6171078 *14 août 19989 janv. 2001Sulzer Electronics AgCentrifugal pump
US6217541 *19 janv. 199917 avr. 2001Kriton Medical, Inc.Blood pump using cross-flow principles
US6222290 *4 août 199924 avr. 2001Sulzer Electronics AgSensor arrangement in an electromagnetic rotary drive and a method for the operation of a rotary drive of this kind
US6223077 *26 janv. 199824 avr. 2001Physio-Control Manufacturing CorporationAutomatic power switching in a defibrillator
US6227797 *30 mars 19998 mai 2001Ventrassist Pty Ltd And University Of TechnologyRotary pump with hydrodynamically suspended impeller
US6234772 *28 avr. 199922 mai 2001Kriton Medical, Inc.Rotary blood pump
US6234998 *20 oct. 199922 mai 2001Kriton Medical, Inc.Sealless rotary blood pump
US6264635 *3 déc. 199824 juil. 2001Kriton Medical, Inc.Active magnetic bearing system for blood pump
US6269266 *23 juil. 199931 juil. 2001Implex Aktiengesellschaft Hearing TechnologyPower supply module for an implantable device
US6278251 *1 sept. 199921 août 2001Sulzer Electronics AgPermanent magnetically excited electrical rotary drive
US6368083 *13 oct. 20009 avr. 2002Kriton Medical, Inc.Sealless rotary blood pump
US6623420 *15 août 200223 sept. 2003Apex Medical, Inc.Physiological heart pump control
US6688861 *26 déc. 200110 févr. 2004Heartware, Inc.Sealless rotary blood pump
US6736770 *27 août 200118 mai 2004Cochlear LimitedImplantable medical device comprising an hermetically sealed housing
US6866625 *20 avr. 200015 mars 2005Ventrassist Pty LtdRotary blood pump and control system therefor
US7645225 *19 mars 200112 janv. 2010Alexander MedvedevChronic performance control system for rotodynamic blood pumps
US20010009645 *27 déc. 200026 juil. 2001Hiroyuki NodaMagnetically driven axial-flow pump
US20020051551 *27 août 20012 mai 2002Hans LeysiefferImplantable medical device comprising an hermetically sealed housing
US20020183628 *31 mai 20025 déc. 2002Sanford ReichPressure sensing endograft
US20040084398 *20 juil. 20016 mai 2004Klaus BreitschwerdtModule, especially a wafer module
US20040084399 *28 mai 20036 mai 2004Shipley Company, L.L.C.Process of producing printed circuit boards and the circuit boards formed thereby
US20040234397 *2 févr. 200425 nov. 2004Heartware, Inc. (A Delaware Corporation)Sealless rotary blood pump
US20040236173 *28 juin 200425 nov. 2004Anthony VioleImplantable heart assist system and method of applying same
US20050131487 *31 janv. 200516 juin 2005Boveja Birinder R.Method and system for providing electrical pulses to gastric wall of a patient with rechargeable implantable pulse generator for treating or controlling obesity and eating disorders
US20050187594 *20 févr. 200425 août 2005Hatlestad John D.System and method for transmitting energy to and establishing a communications network with one or more implanted devices
US20060069412 *30 sept. 200430 mars 2006Codman Neuro Sciences SarlDual power supply switching circuitry for use in a closed system
US20070231135 *30 mars 20074 oct. 2007Orqis Medical CorporationRotary Blood Pump
US20080080983 *4 déc. 20073 avr. 2008Wampler Richard KRotary Blood Pump With Opposing Spindle Magnets, Bore And Drive Windings
US20080085184 *4 déc. 200710 avr. 2008Wampler Richard KRotary Blood Pump With Opposing Spindle Magnets And Contoured Housing
US20080089779 *4 déc. 200717 avr. 2008Wampler Richard KRotary Blood Pump
US20080089797 *4 déc. 200717 avr. 2008Wampler Richard KRotary Blood Pump
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US83940094 mars 201112 mars 2013Minnetronix, Inc.Portable controller with integral power source for mechanical circulation support systems
US85567954 mars 201115 oct. 2013Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US856250830 déc. 200922 oct. 2013Thoratec CorporationMobility-enhancing blood pump system
US85855714 mars 201119 nov. 2013Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US862044716 déc. 201131 déc. 2013Abiomed Inc.Transcutaneous energy transfer coil with integrated radio frequency antenna
US8628460 *20 sept. 201014 janv. 2014Heartware, Inc.Hard-wired implanted controller system
US86907492 nov. 20108 avr. 2014Anthony NunezWireless compressible heart pump
US875325611 oct. 201317 juin 2014Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US876678816 déc. 20111 juil. 2014Abiomed, Inc.Transcutaneous energy transfer system with vibration inducing warning circuitry
US88278887 mars 20139 sept. 2014Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US895627516 juin 201417 févr. 2015Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US900246816 déc. 20117 avr. 2015Abiomed, Inc.Automatic power regulation for transcutaneous energy transfer charging system
US900246916 déc. 20117 avr. 2015Abiomed, Inc.Transcutaneous energy transfer system with multiple secondary coils
US9005105 *9 janv. 201414 avr. 2015Heartware, Inc.Hard-wired implanted controller system
US922082616 déc. 201129 déc. 2015Abiomed, Inc.Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system
US928704029 juil. 201315 mars 2016Thoratec CorporationSelf-tuning resonant power transfer systems
US9364595 *12 oct. 200914 juin 2016Peter ForsellHeart help device, system, and method
US95838746 oct. 201528 févr. 2017Thoratec CorporationMultiaxial connector for implantable devices
US959239729 juil. 201314 mars 2017Thoratec CorporationThermal management for implantable wireless power transfer systems
US962994815 avr. 201525 avr. 2017Tc1 LlcMethods for upgrading ventricle assist devices
US968031017 mars 201413 juin 2017Thoratec CorporationIntegrated implantable TETS housing including fins and coil loops
US974428015 avr. 201529 août 2017Tc1 LlcMethods for LVAD operation during communication losses
US978252727 mai 200910 oct. 2017Tc1 LlcMonitoring of redundant conductors
US97892376 mars 201717 oct. 2017Tc1 LlcSystems for upgrading ventricle assist devices
US980586329 juil. 201331 oct. 2017Thoratec CorporationMagnetic power transmission utilizing phased transmitter coil arrays and phased receiver coil arrays
US20070173898 *20 déc. 200626 juil. 2007Ayre Peter JEmergency controller for a medical device
US20100305692 *27 mai 20092 déc. 2010Thomas Douglas CMonitoring of redundant conductors
US20110071336 *20 sept. 201024 mars 2011Barry YomtovHard-wired implanted controller system
US20110160516 *30 déc. 200930 juin 2011Thoratec CorporationMobility-Enhancing Blood Pump System
US20110196483 *12 oct. 200911 août 2011Milux Holding SaHeart help device, system, and method
US20110218383 *4 mars 20118 sept. 2011Minnetronix Inc.Portable controller and power source for mechanical circulation support systems
US20110218384 *4 mars 20118 sept. 2011Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US20110218385 *4 mars 20118 sept. 2011Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
US20140073838 *18 oct. 201313 mars 2014Thoratec CorporationMobility-Enhancing Blood Pump System
US20140128660 *9 janv. 20148 mai 2014Heartware, Inc.Hard-wired implanted controller system
US20150157778 *6 avr. 201211 juin 2015Tohoku UniversityMagnetic driving pump device
US20150174309 *6 mars 201525 juin 2015Heartware, Inc.Hard-wired implanted controller system
US20160095968 *23 sept. 20157 avr. 2016Heartware, Inc.Back Up Controller System With Updating
CN102497910A *21 sept. 201013 juin 2012海德威公司Hard-wired implanted controller system
CN105879134A *16 mai 201624 août 2016北京精密机电控制设备研究所Monitor for ventricular assist apparatus and monitoring method of monitor
EP2480284A1 *21 sept. 20101 août 2012Heartware, Inc.Hard-wired implanted controller system
EP2480284A4 *21 sept. 20109 juil. 2014Heartware IncHard-wired implanted controller system
EP2530789A3 *30 déc. 200927 févr. 2013Thoratec CorporationMobility-enhancing blood pump system
WO2011035308A1 *21 sept. 201024 mars 2011Heartware, Inc.Hard-wired implanted controller system
WO2011081626A1 *30 déc. 20097 juil. 2011Thoratec CorporationMobility-enhancing blood pump system
WO2011109773A1 *4 mars 20119 sept. 2011Minnetronix Inc.Portable controller with integral power source for mechanical circulation support systems
WO2015160992A1 *15 avr. 201522 oct. 2015Thoratec CorporationMethods and systems for lvad operation during communication losses
WO2017087380A1 *15 nov. 201626 mai 2017Tc1 LlcSystem architecture that allows patient replacement of vad controller/interface module without disconnection of old module
Classifications
Classification aux États-Unis600/16, 607/34, 607/57
Classification internationaleA61M1/12
Classification coopérativeA61M1/101, A61M1/1017, A61M2205/8243, A61M1/122, A61M1/1086, A61M1/1001, A61M2205/3507, A61M1/127, A61N1/36
Classification européenneA61M1/12F, A61M1/10C
Événements juridiques
DateCodeÉvénementDescription
27 mars 2007ASAssignment
Owner name: VENTRASSIST PTY LTD, AUSTRALIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CROSBY, PETER ANDREW;WOODARD, JOHN CAMPBELL;REEL/FRAME:019073/0595;SIGNING DATES FROM 20070301 TO 20070302
17 mars 2010ASAssignment
Owner name: THORATEC CORPORATION,CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VENTRASSIST PTY LTD.;REEL/FRAME:024091/0386
Effective date: 20100121
Owner name: THORATEC CORPORATION, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VENTRASSIST PTY LTD.;REEL/FRAME:024091/0386
Effective date: 20100121